UAEM - Licensing and patenting practices of UK research institutions 2019-2020

Sarai Keestra made this Freedom of Information request to University College London

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

The request was successful.

Dear University College London,

We have previously sent FOI requests asking for information about the licensing practices of UK universities. This was concerning the time period 18th October 2018 to 18th October 2019. We are now looking to update the information for the following year, 19th October 2019 to 19th October 2020.

The updated request is listed below:

For the purpose of clarity, please adhere to the following definitions when answering these questions:

Definitions
Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online [https://tinyurl.com/y5dwc2qv]

A patent grants an inventor the exclusive rights to his or her invention. A patent holder can stop other people from selling, manufacturing, producing, or using the invention for a certain period of time.
Source: Upcouncil, available online [https://www.upcounsel.com/what-is-a-pate...

Licence: Permission for the licensee to use the intellectual property rights
Source: TaylorWessing, available online [https://www.taylorwessing.com/download/a...

Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.

Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [https://www.taylorwessing.com/synapse/co...

Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’
Source: WHO, available online [https://www.who.int/health-technology-as...

START FOI request:
Q1. Has the university committed to licensing its medical discoveries in ways that promote access and affordability in Low- and Middle- Income Countries? If yes, please provide a link or PDF to the relevant policy document.

Q2. Please provide an Excel spreadsheet with headings as displayed below with all the health technologies LICENSED by the university in the period 19th October 2019 to 19th October 2020 AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)

Q3. Please provide a list of patents granted to your organization in the period 19th October 2019 to 19th October 2020, listed by patent family, indicating countries/regions in which the patent has been granted.

Q4. In the period 19th October 2019 to 19th October 2020, has the university shared its best practices for promoting access to medicines through non-exclusive licensing by carrying out any of the following activities?

❏ Contributed sample clauses to the AUTM Global Health Toolkit
❏ Published an article, guidance, or other literature on access licensing practices
❏ Formally presented on access licensing practices at an academic or professional event, or at another university
❏ Informally shared or discussed access licensing practices with administrators at other universities
❏ Other
❏ None
(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in the period 19th October 2019 to 19th October 2020 to improve access to the technologies they license in low-and middle-income settings?

END FOI request.
If you have any questions please do not hesitate to contact me by email.

Yours faithfully,

Sarai Keestra

Finance.FOI Requests, University College London

If you have submitted a Freedom of Information request please accept this
email as acknowledgement that your request has been received. You should
expect a response from us within 20 working days. 

“You will appreciate that all information requests place some degree of
demand on a public authority’s resources in terms of costs and staff time
and that UCL may need to prioritise resources to other areas, or adapt its
usual approach to information compliance work, in order to meet the
unprecedented challenges we are all facing during the Coronavirus
(COVID-19) pandemic.

 

Therefore, we need to advise you may experience delays in receiving
responses to information rights requests during the Coronavirus (COVID-19)
pandemic.”

 

For details on how we use your personal information, please see UCL's
general privacy
notice: [1]www.ucl.ac.uk/legal-services/privacy/general-privacy-notice
Data Protection & FOI
Legal Services
UCL

References

Visible links
1. https://www.ucl.ac.uk/legal-services/pri...

Finance.FOI Requests, University College London

2 Attachments

Dear Ms Keestra,

 

Apologies for the delay in responding to your request for information.

 

We have completed the compilation of information in response to your
request.

 

We can confirm that we do hold information of the description specified in
your request and this information is provided below and attached.

 

Your request and our response

 

We have previously sent FOI requests asking for information about the
licensing practices of UK universities. This was concerning the time
period 18th October 2018 to 18th October 2019. We are now looking to
update the information for the following year, 19th October 2019 to 19th
October 2020.

 

The updated request is listed below:

 

For the purpose of clarity, please adhere to the following definitions
when answering these questions:

 

Definitions

 

Low and middle income country: A country that is defined as ‘low’,
‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year
2018. Income status defined by GNI per capita.

 

Source: World bank, available online [https://tinyurl.com/y5dwc2qv]

 

A patent grants an inventor the exclusive rights to his or her invention.
A patent holder can stop other people from selling, manufacturing,
producing, or using the invention for a certain period of time.

 

Source: Upcouncil, available online
[https://www.upcounsel.com/what-is-a-pate...

 

Licence: Permission for the licensee to use the intellectual property
rights

 

Source: TaylorWessing, available online
[https://www.taylorwessing.com/download/a...

 

Exclusive Licence: A licence that allows only the named licensee to
exploit the relevant IP rights, the licensor is also excluded from
exploiting these IP rights.

 

Non-Exclusive Licence: A licence that grants any number of licensees to
exploit the IP.

 

Source: TaylorWessing, available online
[https://www.taylorwessing.com/synapse/co...

 

Health Technology: ‘Health technology as defined by the WHO: “A health
technology is the application of organized knowledge and skills in the
form of devices, medicines, vaccines, procedures and systems developed to
solve a health problem and improve quality of lives.’

 

Source: WHO, available online
[https://www.who.int/health-technology-as...

 

Q1. Has the university committed to licensing its medical discoveries in
ways that promote access and affordability in Low- and Middle- Income
Countries? If yes, please provide a link or PDF to the relevant policy
document.

 

Response from UCL Business Ltd (UCLB): Yes. Please find attached UCL’s
Statement of Principles and Strategies for the Equitable Dissemination of
Medical Technologies.

 

Q2. Please provide an Excel spreadsheet with headings as displayed below
with all the health technologies LICENSED by the university in the period
19th October 2019 to 19th October 2020 AND specify which countries they
were licensed in AND specify whether they are exclusive or non-exclusive
licenses.

 

Health Technology Licensed | Country of Licensing | Type of License
(Exclusive or Non-Exclusive)

 

UCLB: Yes. Please see attached PDF document.

 

Q3. Please provide a list of patents granted to your organization in the
period 19th October 2019 to 19th October 2020, listed by patent family,
indicating countries/regions in which the patent has been granted.

 

UCLB: Yes. Please see attached PDF document.

 

Q4. In the period 19th October 2019 to 19th October 2020, has the
university shared its best practices for promoting access to medicines
through non-exclusive licensing by carrying out any of the following
activities?

 

❏ Contributed sample clauses to the AUTM Global Health Toolkit

 

❏ Published an article, guidance, or other literature on access licensing
practices

 

❏ Formally presented on access licensing practices at an academic or
professional event, or at another university

 

❏ Informally shared or discussed access licensing practices with
administrators at other universities

 

❏ Other

 

❏ None

 

(Tick as appropriate)

 

UCLB:

 

❏ Contributed sample clauses to the AUTM Global Health Toolkit

❏ Published an article, guidance, or other literature on access licensing
practices ❏ Formally presented on access licensing practices at an
academic or professional event, or at another university

❏ Informally shared or discussed access licensing practices with
administrators at other universities

❏ Other: With regard to Health Technology, as a COVID-19 response UCLB
created non-exclusive licences of the designs of a breathing aid, known as
Continuous Positive Airway Pressure (CPAP), to help COVID-19 patients with
serious respiratory problems to breathe more easily and out of intensive
care. This is a project led by engineers at UCL and clinicians at UCLH
working collaboratively with Mercedes-AMG High Performance Powertrains.

 

Q5. What actions has the technology transfer office (TTO) undertaken in
the period 19th October 2019 to 19th October 2020 to improve access to the
technologies they license in low-and middle-income settings?

 

UCLB: Please see our answer to question 4 above. We also continue to
insist on wording in licences to facilitate such access to the
technologies.

 

You are free to use any information supplied for your own use, including
for non-commercial research purposes. The information may also be used for
the purposes of news reporting. However, any other type of re-use, for
example by publishing or issuing copies to the public, will require the
permission of the copyright owner.

 

If you are unhappy with our response to your request and wish to make a
complaint or request a review of our decision, please email
[1][email address]. Emails should include the words ‘Internal
Review’ in the subject and be marked For the Attention of the Chief
Operating Officer, alternatively you should write to:

 

Chief Operating Officer

University College London

Gower Street

London

WC1E 6BT

 

If you are not content with the outcome of the internal review, you may
apply directly to the Information Commissioner at the address given below.
You should do this within two months of our final decision. (Please note,
complaints and requests for internal review received more than two months
after the initial decision will not be handled.)

 

If you have any queries or concerns, please contact me using the details
provided in this email and including the request reference number.

 

Further information on the Freedom of Information Act is available from
the Information Commissioner’s Office:

 

Wycliffe House

Water Lane

Wilmslow

SK9 5AF

 

01625 545700

[2]www.ico.org.uk

[3][email address]

 

Kind regards,          

 

Mehwish Sultan

Data Protection and Freedom of Information Adviser

University College London

Legal Services

E: [4][email address]; Data Protection: [5][email address];
FOI: [6][UCL request email].

Office phone: +44 (0)203 108 7862 (internal extension: 57862); Mobile: +44
(0)7525285822

 

Working hours: Please note that my current working hours are Monday to
Friday 8am – 4pm.

 

References

Visible links
1. mailto:[email address]
2. http://www.ico.org.uk/
3. mailto:[email address]
4. mailto:[email address]
5. mailto:[email address]
6. mailto:[UCL request email]